Total Payments
$79,930
2023 Payments
$383.27
Companies
36
Transactions
444
Medicare Patients
24,925
Medicare Billing
$1.6M
Payment Breakdown by Category
Other$56,125 (70.2%)
Consulting$8,875 (11.1%)
Food & Beverage$8,445 (10.6%)
Travel$6,166 (7.7%)
Education$318.90 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $56,125 | 21 | 70.2% |
| Consulting Fee | $8,875 | 6 | 11.1% |
| Food and Beverage | $8,445 | 388 | 10.6% |
| Travel and Lodging | $6,166 | 24 | 7.7% |
| Education | $318.90 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $49,727 | 92 | $0 (2021) |
| PFIZER INC. | $14,598 | 53 | $0 (2021) |
| Allergan Inc. | $8,480 | 15 | $0 (2019) |
| Merz North America, Inc. | $1,702 | 7 | $0 (2019) |
| Janssen Biotech, Inc. | $768.86 | 47 | $0 (2023) |
| AbbVie Inc. | $630.72 | 37 | $0 (2021) |
| Sun Pharmaceutical Industries Inc. | $420.36 | 17 | $0 (2023) |
| Amgen Inc. | $369.99 | 19 | $0 (2021) |
| GENZYME CORPORATION | $360.39 | 19 | $0 (2023) |
| Lilly USA, LLC | $351.29 | 21 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $383.27 | 13 | Sun Pharmaceutical Industries Inc. ($235.83) |
| 2022 | $186.66 | 6 | Janssen Biotech, Inc. ($99.99) |
| 2021 | $4,193 | 35 | Galderma Laboratories, L.P. ($3,622) |
| 2020 | $4,164 | 65 | Galderma Laboratories, L.P. ($3,070) |
| 2019 | $12,336 | 93 | Galderma Laboratories, L.P. ($9,691) |
| 2018 | $34,264 | 122 | Galderma Laboratories, L.P. ($17,689) |
| 2017 | $24,404 | 110 | Galderma Laboratories, L.P. ($15,655) |
All Payment Transactions
444 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT, DUPIXENT | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: Immunology | ||||||
| 10/03/2023 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $8.28 | General |
| Category: Dermatology | ||||||
| 09/11/2023 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: Dermatology | ||||||
| 08/22/2023 | Sun Pharmaceutical Industries Inc. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Oncology | ||||||
| 08/01/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $42.99 | General |
| Category: Immunology | ||||||
| 07/11/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: Immunology | ||||||
| 07/10/2023 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $2.54 | General |
| Category: Dermatology | ||||||
| 05/23/2023 | Sun Pharmaceutical Industries Inc. | — | Education | In-kind items and services | $60.99 | General |
| 05/16/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Dermatology | ||||||
| 05/09/2023 | Sun Pharmaceutical Industries Inc. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: Oncology | ||||||
| 05/02/2023 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $117.44 | General |
| Category: Dermatology | ||||||
| 03/07/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/06/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: DERMATOLOGY | ||||||
| 12/07/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Immunology | ||||||
| 10/13/2022 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.98 | General |
| 07/06/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Immunology | ||||||
| 05/04/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: DERMATOLOGY | ||||||
| 03/15/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Immunology | ||||||
| 02/28/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 08/10/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2021 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Immunology | ||||||
| 08/03/2021 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.26 | General |
| 07/30/2021 | EPI Health, LLC | CLODERM (Drug), MINOLIRA EXTENDED RELEASE, WYNZORA | Food and Beverage | Cash or cash equivalent | $17.22 | General |
| Category: DERMATOLOGY | ||||||
| 07/22/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $16.62 | General |
| 07/20/2021 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 5,672 | 10,386 | $1.7M | $357,316 |
| 2022 | 35 | 6,106 | 11,453 | $1.4M | $397,906 |
| 2021 | 38 | 6,580 | 12,592 | $1.5M | $452,312 |
| 2020 | 40 | 6,567 | 12,409 | $1.5M | $404,276 |
Total Patients
24,925
Total Services
46,840
Medicare Billing
$1.6M
Procedure Codes
146
All Medicare Procedures & Services
146 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,321 | 1,791 | $458,940 | $99,656 | 21.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 715 | 863 | $277,054 | $63,129 | 22.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 842 | 1,140 | $215,761 | $37,200 | 17.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 209 | 268 | $97,524 | $21,779 | 22.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 323 | 373 | $106,345 | $21,316 | 20.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 665 | 3,914 | $73,608 | $18,094 | 24.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 384 | 479 | $75,755 | $15,994 | 21.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 83 | 108 | $51,498 | $12,077 | 23.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 234 | 289 | $46,426 | $8,163 | 17.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 33 | 33 | $27,868 | $6,565 | 23.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 43 | 56 | $28,679 | $6,362 | 22.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 83 | 83 | $26,271 | $5,609 | 21.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 93 | 145 | $20,382 | $5,256 | 25.8% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 23 | 24 | $13,821 | $3,256 | 23.6% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 33 | 35 | $12,512 | $3,087 | 24.7% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 20 | 27 | $13,642 | $3,015 | 22.1% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 13 | 13 | $11,678 | $2,838 | 24.3% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 28 | 33 | $13,661 | $2,702 | 19.8% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 29 | 30 | $11,277 | $2,664 | 23.6% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 16 | 17 | $9,146 | $2,343 | 25.6% |
| 29580 | Strapping, unna boot | Office | 2023 | 33 | 60 | $11,175 | $2,305 | 20.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 22 | $15,236 | $2,299 | 15.1% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 31 | 39 | $7,787 | $1,737 | 22.3% |
| 17280 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 15 | 17 | $6,844 | $1,631 | 23.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 20 | 20 | $7,015 | $1,566 | 22.3% |
About Dr. Michael Cogburn, MD
Dr. Michael Cogburn, MD is a Dermatology healthcare provider based in Arden, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912972811.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Cogburn, MD has received a total of $79,930 in payments from pharmaceutical and medical device companies, with $383.27 received in 2023. These payments were reported across 444 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($56,125).
As a Medicare-enrolled provider, Cogburn has provided services to 24,925 Medicare beneficiaries, totaling 46,840 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 146 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Arden, NC
- Active Since 02/22/2006
- Last Updated 08/23/2012
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1912972811
Products in Payments
- EUCRISA (Drug) $13,316
- TALTZ (Drug) $351.29
- Erivedge (Biological) $329.28
- Humira (Biological) $327.89
- TREMFYA (Drug) $318.94
- Enbrel (Biological) $283.33
- REMICADE (Biological) $281.45
- DUPIXENT (Biological) $269.70
- COSENTYX (Biological) $250.49
- Tremfya (Drug) $240.84
- XEOMIN (Biological) $237.95
- TARGADOX (Drug) $216.02
- DORYX (Drug) $200.01
- ILUMYA (Biological) $161.51
- STELARA (Biological) $153.03
- HUMIRA (Biological) $150.44
- DUPIXENT (Drug) $124.13
- DUPIXENT DUPILUMAB INJECTION (Biological) $91.01
- ENSTILAR (Drug) $88.21
- Otezla (Drug) $86.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.